Literature DB >> 17694277

Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells.

David A Rider1, Thenmozhi Nalathamby, Victor Nurcombe, Simon M Cool.   

Abstract

Bone marrow-derived mesenchymal stem cells consist of a developmentally heterogeneous population of cells obtained from colony forming progenitors. As these colonies express the alpha-1 integrin (CD49a), here we single-cell FACS sorted CD49a+ cells from bone marrow in order to create clones and then compared their colony forming efficiency and multilineage differentiation capacity to the unsorted cells. Following selection, 40% of the sorted CD49a+ cells formed colonies, whereas parental cells failed to form colonies following limited dilution plating at 1 cell/well. Following ex vivo expansion, clones shared a similar morphology to the parental cell line, and also demonstrated enhanced proliferation. Further analysis by flow cytometry using a panel of multilineage markers demonstrated that the CD49a+ clones had enhanced expression of CD90 and CD105 compared to unsorted cells. Culturing cells in adipogenic, osteogenic or chondrogenic medium for 7, 10 and 15 days respectively and then analysing them by quantitative PCR demonstrated that CD49a+ clones readily underwent multlineage differentiation into fat, bone and cartilage compared to unsorted cells. These results thus support the use of CD49a selection for the enrichment of mesenchymal stem cells, and describes a strategy for selecting the most multipotential cells from a heterogeneous pool of bone marrow mononuclear stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694277     DOI: 10.1007/s10735-007-9128-z

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

1.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

2.  Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers.

Authors:  H S Goodwin; A R Bicknese; S N Chien; B D Bogucki; C O Quinn; D A Wall
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

3.  STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro.

Authors:  Karina Stewart; Peter Monk; Susan Walsh; Carolyn M Jefferiss; Julie Letchford; Jon N Beresford
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

Review 4.  Mesenchymal stem cells: paradoxes of passaging.

Authors:  Elisabeth H Javazon; Kirstin J Beggs; Alan W Flake
Journal:  Exp Hematol       Date:  2004-05       Impact factor: 3.084

5.  Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers.

Authors:  James B Mitchell; Kevin McIntosh; Sanjin Zvonic; Sara Garrett; Z Elizabeth Floyd; Amy Kloster; Yuan Di Halvorsen; Robert W Storms; Brian Goh; Gail Kilroy; Xiying Wu; Jeffrey M Gimble
Journal:  Stem Cells       Date:  2005-12-01       Impact factor: 6.277

6.  Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells.

Authors:  Santiago Roura; Jordi Farré; Carolina Soler-Botija; Anna Llach; Leif Hove-Madsen; Jordi J Cairó; Francesc Gòdia; Juan Cinca; Antoni Bayes-Genis
Journal:  Eur J Heart Fail       Date:  2006-02-28       Impact factor: 15.534

7.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

Review 8.  Mesenchymal stem cells.

Authors:  Brenton Short; Nathalie Brouard; Teresa Occhiodoro-Scott; Anand Ramakrishnan; Paul J Simmons
Journal:  Arch Med Res       Date:  2003 Nov-Dec       Impact factor: 2.235

9.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

10.  Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype.

Authors:  Frederic Deschaseaux; Florelle Gindraux; Rafika Saadi; Laurent Obert; David Chalmers; Patrick Herve
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

View more
  22 in total

1.  Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow.

Authors:  Torben Helledie; Christian Dombrowski; Bina Rai; Zophia X H Lim; Ian Lee Hock Hin; David A Rider; Gary S Stein; Wanjin Hong; Andre J van Wijnen; James H Hui; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells Dev       Date:  2012-01-18       Impact factor: 3.272

Review 2.  Control of cell fate decisions.

Authors:  Simon M Cool
Journal:  J Mol Histol       Date:  2007-10-24       Impact factor: 2.611

3.  A novel combination of homeobox genes is expressed in mesenchymal chorionic stem/stromal cells in first trimester and term pregnancies.

Authors:  Haiying Liu; Padma Murthi; Sharon Qin; Gina D Kusuma; Anthony J Borg; Martin Knöfler; Peter Haslinger; Ursula Manuelpillai; Mark D Pertile; Mohamed Abumaree; Bill Kalionis
Journal:  Reprod Sci       Date:  2014-04-01       Impact factor: 3.060

4.  Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Authors:  Judith Lorant; Charlotte Saury; Cindy Schleder; Florence Robriquet; Blandine Lieubeau; Elisa Négroni; Isabelle Leroux; Lucie Chabrand; Sabrina Viau; Candice Babarit; Mireille Ledevin; Laurence Dubreil; Antoine Hamel; Armelle Magot; Chantal Thorin; Laëtitia Guevel; Bruno Delorme; Yann Péréon; Gillian Butler-Browne; Vincent Mouly; Karl Rouger
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

5.  Epiphyseal Chondroprogenitors Provide a Stable Cell Source for Cartilage Cell Therapy.

Authors:  Salim Darwiche; Corinne Scaletta; Wassim Raffoul; Dominique P Pioletti; Lee Ann Applegate
Journal:  Cell Med       Date:  2012-05-08

6.  Conditioned medium from renal tubular epithelial cells initiates differentiation of human mesenchymal stem cells.

Authors:  P C Baer; J Bereiter-Hahn; C Missler; M Brzoska; R Schubert; S Gauer; H Geiger
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

7.  Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs.

Authors:  J T Connelly; C G Wilson; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2008-02-21       Impact factor: 6.576

8.  FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential.

Authors:  S Hagmann; B Moradi; S Frank; T Dreher; P W Kämmerer; W Richter; T Gotterbarm
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

9.  Isolation of osteoprogenitors from murine bone marrow by selection of CD11b negative cells.

Authors:  A Dumas; M A Le Drévo; M F Moreau; C Guillet; M F Baslé; D Chappard
Journal:  Cytotechnology       Date:  2009-02-17       Impact factor: 2.058

10.  Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells.

Authors:  Premjit Arpornmaeklong; Shelley E Brown; Zhuo Wang; Paul H Krebsbach
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.